Cargando…
Integration of plasma and CSF metabolomics with CSF proteomic reveals novel associations between lipid mediators and central nervous system vascular and energy metabolism
Integration of the omics data, including metabolomics and proteomics, provides a unique opportunity to search for new associations within metabolic disorders, including Alzheimer’s disease. Using metabolomics, we have previously profiled oxylipins, endocannabinoids, bile acids, and steroids in 293 C...
Autores principales: | Borkowski, Kamil, Seyfried, Nicholas T., Arnold, Matthias, Lah, James J., Levey, Allan I., Hales, Chadwick M., Dammer, Eric B., Blach, Colette, Louie, Gregory, Kaddurah-Daouk, Rima, Newman, John W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10447532/ https://www.ncbi.nlm.nih.gov/pubmed/37612324 http://dx.doi.org/10.1038/s41598-023-39737-8 |
Ejemplares similares
-
Association of plasma and CSF cytochrome P450, soluble epoxide hydrolase, and ethanolamide metabolism with Alzheimer’s disease
por: Borkowski, Kamil, et al.
Publicado: (2021) -
CSF complement 3 and factor H are staging biomarkers in Alzheimer’s disease
por: Hu, William T., et al.
Publicado: (2016) -
Comparative brain metabolomics reveals shared and distinct metabolic alterations in Alzheimer’s disease and progressive supranuclear palsy
por: Batra, Richa, et al.
Publicado: (2023) -
Serum metabolomic biomarkers of perceptual speed in cognitively normal and mildly impaired subjects with fasting state stratification
por: Borkowski, Kamil, et al.
Publicado: (2021) -
Signatures of glial activity can be detected in the CSF proteome
por: Eninger, Timo, et al.
Publicado: (2022)